FINWIRES · TerminalLIVE
FINWIRES

Teva Pharmaceutical Industries Insider Sold Shares Worth $5,457,375, According to a Recent SEC Filing

By

Eliyahu Sharon Kalif, Executive Vice President, Chief Financial Officer, on May 14, 2026, sold 153,251 shares in Teva Pharmaceutical Industries (TEVA) for $5,457,375. Following the Form 4 filing with the SEC, Kalif has control over a total of 172,184 ordinary shares of the company, with 172,184 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000119312526228870/xslF345X05/ownership.xml

Related Articles